Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Th17 Polarization under Hypoxia Results in Increased IL-10 Production in a Pathogen-Independent Manner.

Volchenkov R, Nygaard V, Sener Z, Skålhegg BS.

Front Immunol. 2017 Jun 19;8:698. doi: 10.3389/fimmu.2017.00698. eCollection 2017.

2.

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors.

Seip K, Fleten KG, Barkovskaya A, Nygaard V, Haugen MH, Engesæter BØ, Mælandsmo GM, Prasmickaite L.

Oncotarget. 2016 Apr 12;7(15):19997-20015. doi: 10.18632/oncotarget.7671.

3.

Methods that remove batch effects while retaining group differences may lead to exaggerated confidence in downstream analyses.

Nygaard V, Rødland EA, Hovig E.

Biostatistics. 2016 Jan;17(1):29-39. doi: 10.1093/biostatistics/kxv027. Epub 2015 Aug 13.

4.

Melanoma brain colonization involves the emergence of a brain-adaptive phenotype.

Nygaard V, Prasmickaite L, Vasiliauskaite K, Clancy T, Hovig E.

Oncoscience. 2014 Jan 10;1(1):82-94. eCollection 2014.

5.

Identifying pathogenic processes by integrating microarray data with prior knowledge.

Nygård S, Reitan T, Clancy T, Nygaard V, Bjørnstad J, Skrbic B, Tønnessen T, Christensen G, Hovig E.

BMC Bioinformatics. 2014 Apr 24;15:115. doi: 10.1186/1471-2105-15-115.

6.

The Genomic HyperBrowser: an analysis web server for genome-scale data.

Sandve GK, Gundersen S, Johansen M, Glad IK, Gunathasan K, Holden L, Holden M, Liestøl K, Nygård S, Nygaard V, Paulsen J, Rydbeck H, Trengereid K, Clancy T, Drabløs F, Ferkingstad E, Kalas M, Lien T, Rye MB, Frigessi A, Hovig E.

Nucleic Acids Res. 2013 Jul;41(Web Server issue):W133-41. doi: 10.1093/nar/gkt342. Epub 2013 Apr 30.

7.

The differential disease regulome.

Sandve GK, Gundersen S, Rydbeck H, Glad IK, Holden L, Holden M, Liestøl K, Clancy T, Drabløs F, Ferkingstad E, Johansen M, Nygaard V, Tøstesen E, Frigessi A, Hovig E.

BMC Genomics. 2011 Jul 7;12:353. doi: 10.1186/1471-2164-12-353.

8.

Immunological network signatures of cancer progression and survival.

Clancy T, Pedicini M, Castiglione F, Santoni D, Nygaard V, Lavelle TJ, Benson M, Hovig E.

BMC Med Genomics. 2011 Mar 31;4:28. doi: 10.1186/1755-8794-4-28.

9.

The Genomic HyperBrowser: inferential genomics at the sequence level.

Sandve GK, Gundersen S, Rydbeck H, Glad IK, Holden L, Holden M, Liestøl K, Clancy T, Ferkingstad E, Johansen M, Nygaard V, Tøstesen E, Frigessi A, Hovig E.

Genome Biol. 2010;11(12):R121. doi: 10.1186/gb-2010-11-12-r121. Epub 2010 Dec 23.

10.

Validation of oligoarrays for quantitative exploration of the transcriptome.

Nygaard V, Liu F, Holden M, Kuo WP, Trimarchi J, Ohno-Machado L, Cepko CL, Frigessi A, Glad IK, Wiel MA, Hovig E, Lyng H.

BMC Genomics. 2008 May 30;9:258. doi: 10.1186/1471-2164-9-258.

11.
12.

Limitations of mRNA amplification from small-size cell samples.

Nygaard V, Holden M, Løland A, Langaas M, Myklebost O, Hovig E.

BMC Genomics. 2005 Oct 27;6:147.

13.

Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma.

Trøen G, Nygaard V, Jenssen TK, Ikonomou IM, Tierens A, Matutes E, Gruszka-Westwood A, Catovsky D, Myklebost O, Lauritzsen G, Hovig E, Delabie J.

J Mol Diagn. 2004 Nov;6(4):297-307.

14.

Seed 1-cysteine peroxiredoxin antioxidants are not involved in dormancy, but contribute to inhibition of germination during stress.

Haslekås C, Viken MK, Grini PE, Nygaard V, Nordgard SH, Meza TJ, Aalen RB.

Plant Physiol. 2003 Nov;133(3):1148-57. Epub 2003 Oct 2.

15.

Effects of mRNA amplification on gene expression ratios in cDNA experiments estimated by analysis of variance.

Nygaard V, Løland A, Holden M, Langaas M, Rue H, Liu F, Myklebost O, Fodstad Ø, Hovig E, Smith-Sørensen B.

BMC Genomics. 2003 Mar 23;4(1):11. Epub 2003 Mar 23.

Supplemental Content

Loading ...
Support Center